U.S. markets closed

Colgate-Palmolive Company (CL)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
84.75+0.04 (+0.05%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close84.71
Open85.14
Bid84.77 x 900
Ask84.78 x 1000
Day's Range84.44 - 85.47
52 Week Range58.49 - 86.41
Volume3,135,719
Avg. Volume3,449,913
Market Cap72.645B
Beta (5Y Monthly)0.56
PE Ratio (TTM)27.08
EPS (TTM)3.13
Earnings DateJan 29, 2021
Forward Dividend & Yield1.76 (2.08%)
Ex-Dividend DateOct 22, 2020
1y Target Est83.58
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-26% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is Colgate Palmolive a Buy?
    Motley Fool

    Is Colgate Palmolive a Buy?

    Colgate-Palmolive (NYSE: CL) is a familiar name to many investors. Investing in companies that you understand is always good, and it is one of the key tenets of famed investor Peter Lynch's investing guidelines. Under its leading Colgate brand, the company sells toothpastes and toothbrushes.

  • Colgate Laboratory Tests Show Toothpaste and Mouthwash Neutralize 99.9% of the Virus That Causes COVID-19
    Business Wire

    Colgate Laboratory Tests Show Toothpaste and Mouthwash Neutralize 99.9% of the Virus That Causes COVID-19

    Laboratory studies show that toothpastes containing zinc or stannous and mouthwash formulas with cetylpyridinium chloride (CPC) neutralize the virus that causes COVID-19 by 99.9 percent. The studies are part of a Colgate research program that includes clinical studies among infected people to assess the efficacy of oral care products in reducing the amount of the virus in the mouth, potentially slowing the transmission of the COVID-19 virus.

  • Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Virtual Global Consumer & Retail Conference
    Business Wire

    Colgate-Palmolive Webcasts Fireside Chat at the Morgan Stanley Virtual Global Consumer & Retail Conference

    Colgate-Palmolive (NYSE:CL) Group President, Colgate-Latin America, Asia Pacific & Africa-Eurasia, Panagiotis Tsourapas, will participate in a virtual fireside chat at the Morgan Stanley Global Consumer & Retail Conference on Wednesday, December 2, 2020 at 11:00 a.m. ET.